BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 19748645)

  • 1. Loss of p27 expression in canine mammary tumors and their metastases.
    Klopfleisch R; Schütze M; Gruber AD
    Res Vet Sci; 2010 Apr; 88(2):300-3. PubMed ID: 19748645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of cell cycle regulators p21, p27 and p53 in metastasizing canine mammary adenocarcinomas versus normal mammary glands.
    Klopfleisch R; Gruber AD
    Res Vet Sci; 2009 Aug; 87(1):91-6. PubMed ID: 19185891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of BRCA2 and RAD51 in lymph node metastases of canine mammary adenocarcinomas.
    Klopfleisch R; Gruber AD
    Vet Pathol; 2009 May; 46(3):416-22. PubMed ID: 19176491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin receptor is expressed in normal canine mammary gland and benign adenomas but decreased in metastatic canine mammary carcinomas similar to human breast cancer.
    Klopfleisch R; Hvid H; Klose P; da Costa A; Gruber AD
    Vet Comp Oncol; 2010 Dec; 8(4):293-301. PubMed ID: 21062411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RAD51 protein expression is increased in canine mammary carcinomas.
    Klopfleisch R; Schütze M; Gruber AD
    Vet Pathol; 2010 Jan; 47(1):98-101. PubMed ID: 20080488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased Derlin-1 expression in metastases of canine mammary adenocarcinomas.
    Klopfleisch R; Schütze M; Linzmann H; Brunnberg L; Gruber AD
    J Comp Pathol; 2010 Jan; 142(1):79-83. PubMed ID: 19632687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The combined expression pattern of BMP2, LTBP4, and DERL1 discriminates malignant from benign canine mammary tumors.
    Klopfleisch R; Klose P; Gruber AD
    Vet Pathol; 2010 May; 47(3):446-54. PubMed ID: 20375427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HEPACAM1 and 2 are differentially regulated in canine mammary adenomas and carcinomas and its lymph node metastases.
    Klopfleisch R; Klose P; da Costa A; Brunnberg L; Gruber AD
    BMC Vet Res; 2010 Mar; 6():15. PubMed ID: 20226097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERalpha and p53.
    Morris JS; Nixon C; King OJ; Morgan IM; Philbey AW
    Vet J; 2009 Mar; 179(3):422-9. PubMed ID: 18314357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MUC1 expression in canine malignant mammary tumours and relationship to clinicopathological features.
    de Oliveira JT; Pinho SS; de Matos AJ; Hespanhol V; Reis CA; Gärtner F
    Vet J; 2009 Dec; 182(3):491-3. PubMed ID: 18948041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of transforming growth factor β (TGFβ) and latent TGFβ binding protein (LTBP)-4 expression in late stage canine mammary tumours.
    Klopfleisch R; Schütze M; Gruber AD
    Vet J; 2010 Dec; 186(3):379-84. PubMed ID: 19836277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and significance of PTEN in canine mammary gland tumours.
    Qiu C; Lin D; Wang J; Wang L
    Res Vet Sci; 2008 Oct; 85(2):383-8. PubMed ID: 18082231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical expression of protein p53 in neoplasms of the mammary gland in bitches.
    Rodo A; Malicka E
    Pol J Vet Sci; 2008; 11(2):89-95. PubMed ID: 18683536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical expression of caveolin-1 in normal and neoplastic canine mammary tissue.
    Amorim I; Lopes CC; Faustino AM; Pereira PD
    J Comp Pathol; 2010 Jul; 143(1):39-44. PubMed ID: 20153867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Derlin-1 and stanniocalcin-1 are differentially regulated in metastasizing canine mammary adenocarcinomas.
    Klopfleisch R; Gruber AD
    J Comp Pathol; 2009; 141(2-3):113-20. PubMed ID: 19515379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-associated carbohydrate antigens: Sialyl Lea and T/Tn antigens in canine mammary tumors.
    Nowak M; Madej J; Dziegiel P; Lopuszynski W; Rodo A; Ugorski M
    Vet Pathol; 2009 Mar; 46(2):222-6. PubMed ID: 19261632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of claudin-1, -2, -3, -4, -5 and -7 proteins in benign and malignant canine mammary gland epithelial tumours.
    Jakab C; Halász J; Szász AM; Kiss A; Schaff Z; Rusvai M; Gálfi P; Kulka J
    J Comp Pathol; 2008 Nov; 139(4):238-45. PubMed ID: 18848337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced PTEN protein expression and its prognostic implications in canine and feline mammary tumors.
    Ressel L; Millanta F; Caleri E; Innocenti VM; Poli A
    Vet Pathol; 2009 Sep; 46(5):860-8. PubMed ID: 19429983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of cell cycle control proteins in primary colorectal tumors does not always predict expression in lymph node metastases.
    McKay JA; Douglas JJ; Ross VG; Curran S; Ahmed FY; Loane JF; Murray GI; McLeod HL
    Clin Cancer Res; 2000 Mar; 6(3):1113-8. PubMed ID: 10741741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression of p63 and cytokeratin 5 in mixed tumors of the canine mammary gland provides new insights into the histogenesis of these neoplasms.
    Ramalho LN; Ribeiro-Silva A; Cassali GD; Zucoloto S
    Vet Pathol; 2006 Jul; 43(4):424-9. PubMed ID: 16846983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.